NCT05497349View on ClinicalTrials.gov

Use of Leukocyte-Rich PRP or Leukocyte-Free PRP in the Treatment of Hip Osteoarthritis

NARecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Hip Osteoarthritis
Interventions
OTHER

Leukocyte Rich- PRP injection

Autologous Leukocyte Rich-Platelet Rich Plasma will be injected in the hip joint

OTHER

Leukocyte Poor- PRP injection

Autologous Leukocyte Poor-Platelet Rich Plasma will be injected in the hip joint

Trial Locations (1)

40136

RECRUITING

Istituto Ortopedico Rizzoli, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER